Cannabis Law Report

AUGUST 23, 2022

The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015. By Jennifer L. Mora on August 22, 2022. Last month, on July 13, 2022, Washington, D.C. Mayor Muriel Bowser signed the “ Cannabis Employment Protections Amendment Act of 2022 ” (D.C.

Safety 52

Safety Environment Policy Recreational 52

Cannabis Law Report

JULY 16, 2019

The 40-year-old northeast Pennsylvanian native was diagnosed with Hodgkin’s lymphoma in 2010. In July, 2012, he and his wife settled in south Redding, where, at the time, the outdoor cultivation of medical cannabis was legal for qualified patients. Mike Rubin lives on borrowed time. But Rubin had other ideas.

Patients 40

Patients Cultivation Cannabis Strains 40

Cannabis Law Report

JULY 13, 2019

But the draft law will also introduce an obligation for doctors to share patient data concerning people using prescribed marijuana. Patients will have the right to stop doctors from entering the data in the drug database. Patients taking medicinal cannabis are increasing in the Czech Republic, but the number is still low.

Chronic Pain 40

Chronic Pain Data Patients Decriminalization 40

NORML

FEBRUARY 22, 2019

Legislation is pending, House Bill 2149, to amend the definition of “cannabis” under the 2010 voter-approved medical marijuana law. Update : HB 2149 was approved by the Public Safety Committee on 2/20. Click here to email your lawmakers in support of allowing patients to smoke medical cannabis. AZ resident?

Legislation 176

Legislation Hemp Compliance Compliance 176

Medicinal Genomics

AUGUST 8, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list.

Medicine 52

Medicine Patients Cannabis Therapy 52

Cannabis Law Report

JANUARY 23, 2022

GVHD affects a significant portion of transplant patients, anywhere between 30% and 70% of patients depending on how closely the donor’s tissue matches with the patient. The team recruited 48 Patients with leukaemia or myelodysplastic syndrome. No grades III to IV toxicities were attributed to CBD. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Medicinal Genomics

JULY 18, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list.

Medicine 52

Medicine Patients Cannabis Therapy 52

Cannabis Law Report

JANUARY 3, 2022

In addition, Panaxia is the only company in Europe to have a regulatory permit for the distribution of medical cannabis tablets in France , as part of the French National Agency for Medicines and Health Products Safety (ANSM). About Panaxia Labs Israel. Panaxia Labs Israel, Ltd., Assi Rotbart (LL.

Pharmaceutical 52

Pharmaceutical Chronic Pain Extraction Epilepsy 52

NORML

APRIL 1, 2019

Provisions are included for home cultivation, allowing consumers and patients to grow their own cannabis if they wish; this is similar to the model we see in the thriving craft beer industry in New York. Marijuana prohibition has not increased public safety.

Legalization 158

Legalization Marijuana Legislation Decriminalization 158

Cannabis Law Report

MARCH 9, 2020

The Chinese authorities permitted hemp cultivation in two Chinese provinces that is Yunnan and Heilongjiang , in 2010, having been prohibited for 25 years. Food and food additives imported into China must have Chinese labeling and requirements under the Food Safety Act, i.e. they must be approved for import. Status: Restricted.

Oil 64

Oil CBD Legalization Research and Development 64

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. The states’ situation varies substantially.

Research and Development 52

Research and Development Medicine Access Media 52

Canna Law Blog

JUNE 8, 2020

This includes how patients are treated and managed, including their patient records and how often a patient is seen. Further, physicians must be in complete control of the professional medical corporation and its clinical business and management decisions. Very carefully is the answer.

Treatment 52

Treatment Patients Medicine Business 52

Veriheal

OCTOBER 27, 2020

While working as part of the school safety task force in 2010, Robert received a sprained shoulder and two fractured shin bones from wrestling a student that had assaulted a member of the staff. Under state law, medical cannabis patients are categorized as disabled. About Former NYPD Officer Robert Cascalenda.

Chronic Pain 117

Chronic Pain Cannabis Conditions Medicine 117

Cannabis Law Report

JUNE 26, 2019

First and foremost, I’ll highlight the patient perspective, patients like myself who are legally registered State of Florida Medical Marijuana active ID cardholders. I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

APRIL 8, 2022

The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D., Members of the U.S.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Puff Puff Post

DECEMBER 28, 2018

A sample of 120 patients aged between 5 and 29 years old with mild to severe autism are currently being given two different cannabis oil formulas or placebo. Adi Aran, director of the pediatric neurology unit at the Shaare Zedek Hospital in Jerusalem conducted the study on 70 of his own patients in an observational study.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JUNE 25, 2021

Nutt will lead Awakn’s neuroscience research of psychedelic compounds for treating a broad range of addictions where the consequences for the patient, their family, and society are at present most severe. In 2010, The Times Eureka science magazine included him in the 100 most important figures in British Science, and the only psychiatrist.

Research and Development 66

Research and Development Therapy Medicine Pets 66

SpeedWeed

JULY 19, 2021

The document in question was a 2020 safety study of the vape cartridge additive phytol. Certain vape additives are associated with lung injury, which shows up as cloudy on the left x-ray, and clear after treatment of one suspected VAPI patient in Utah. An alarming study of the vape additive phytol has rocked the cannabis vaping world.

Vaping 52

Vaping Terpenes Data Research and Development 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 19, 2021

Beginning July 1, 2021, local marijuana delivery permits may be issued to medical or retail marijuana stores, or medical or retail marijuana transporters to deliver marijuana to private residences of consumers and patients. Delivery by Denver Marijuana Delivery Permit holders may not deliver between the hours of 12:00 a.m. and 8:00 a.m.,

Marijuana 76

Marijuana Consumption Retail Business 76

Cannabis Law Report

JULY 18, 2019

The Kelly case was decided in January 2010 by the California Supreme Court. The language that appeared on the ballot stated: “Exempts patients and defined caregivers who possess or cultivate cannabis for medical treatment recommended by a physician from criminal laws which otherwise prohibit possession or cultivation of cannabis.

Cultivation 64

Cultivation Environment Cannabis Agriculture 64

Cannabis Law Report

JULY 28, 2021

Based on these promising findings, PharmaDrug reiterates that it remains committed to the clinical development of PD-001 for the treatment of patients suffering from esophageal cancer. Epub 2010 Dec 17. ” Next Steps. Zahedi P, De Souza R, Huynh L, Piquette-Miller M, Allen C. 2011 Feb 7;8(1):260-9. doi: 10.1021/mp100323z.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. He has covered the legal cannabis industry since 2010. Bruce Kennedy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Otherside Farms

MAY 5, 2021

There is a large debate on the safety of medical marijuana. Many people quickly started discovering them in 2010. Over 20% of patients who use vaporizers that suffer from chronic pain, multiple sclerosis, epilepsy, and HIV find life more enjoyable with the use of cannabis strictly for therapeutic purposes.

Vaping 52

Vaping THC Oil Chronic Pain 52

Cannabis Law Report

OCTOBER 20, 2019

She was the Presiding Judge 2009 and 2010 and the co-founder of the Denver County Court Sobriety Court. It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. For patients without insurance, legal botanical marijuana provides an affordable option to relieve their symptoms. Author Biography.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Healer

MAY 10, 2019

The safety profile of cannabis in pregnancy, from the little data available, is comparable to other medications in category C (suspected of causing harmful effects on the fetus that may be reversible). 2010): 91-99. ‘Male–female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function.’

Research and Development 52

Research and Development Cannabinoids Data Environment 52

Cannabis Law Report

FEBRUARY 28, 2019

Missouri just posted rules for medical marijuana patient cards. The floor vote comes one week after the chamber’s Criminal Justice and Public Safety Committee advanced the bill in a 10-9 vote. Here’s the FAQ. The full chamber voted 209-147 in favor of the legislation. New Hampshire House Passes Marijuana Legalization Bill.

Digestion 58

Digestion Legislation Cultivation Hemp 58

Cannabis Law Report

JULY 31, 2019

3] The CSA established five schedules of controlled substances, with Schedule I substances defined as those which have a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. [4] Health and Safety Code § 11362.5. [7] 801, et seq. [4]

Law 40

Law Legalization Marijuana Policy 40

Cannabis Law Report

OCTOBER 17, 2019

Many of these are meant to address public safety risks, especially for young people. In Arizona, medical use has been legal since 2010, with 130 dispensaries now open across the state after two rounds of licensing. alcoholic beverages, caffeine, and tobacco).

Law 40

Law Seed-To-Sale Hemp Recreational 40

The Joint Blog

JUNE 2, 2020

A patient or a leisure seeker should be mindful of the cannabis laws, otherwise your trip to paradise might end up in a nightmare. Remember that he made a similar comment in May 2017 when signing that fiscal year’s appropriations bill into law, and yet no raids against state-legal medical marijuana patients or providers followed.

Decriminalization 29

Decriminalization Recreational Advocacy Policy 29

Cannabis Law Report

JUNE 4, 2021

He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Meadow

JULY 13, 2018

We’ve had a cap on that really since 2010 and one way or another, we’ve codified that now to a number of 30. Certain communities have experienced those impacts very differently so patients have experienced impacts differently. What I do on a regular basis is very much similar to what my colleagues and peers do here.

Wellness and Beauty 40

Wellness and Beauty Consumption Policy Cannabis 40

Cannabis Law Report

MARCH 25, 2019

Permits the distribution of medicinal marihuana only to hospitals and pharmacies registered to dispense Schedule II controlled substances for the purposes of treating glaucoma or the nausea of cancer patients or research approved under the Federal Food, Drug, and Cosmetic Act.”. [ii] 3, 2010 , 124 Stat. 3, 2010 , 124 Stat.

Banking 45

Banking Law Marijuana State Laws 45